Compare CVS Health Corp (CVS) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs CarMax, Inc — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while CarMax, Inc trades at $53.88 (market cap $7.56B). The key difference: CVS Health Corp is far larger — about 14.9× CarMax, Inc's market cap, and CVS Health Corp pays a 3.02% dividend while CarMax, Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and CarMax, Inc for 49 Days on average.
| CVS | KMX | |
|---|---|---|
Market Cap | $112.49B | $7.56B |
Volume | 8,467,392 | 3,338,522 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $64.22 |
52-Week Low | $70.08 | $30.88 |
Typical Hold Time | 83 Days | 49 Days |
Enterprise Value | $174.83B | $25.26B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
CarMax (KMX) trades at $53.79, down 2.71% with bearish technical signals despite recent earnings beats. The company reported strong Q2 2026 results with EPS of $1.16 beating estimates by 58%, driven by 19.5% revenue growth to $7.9 billion. However, net income margin remains thin at 1.06% and the stock faces resistance near $54 with negative cash flow trends. Management's 'Shift into GEAR' strategy shows early traction with improved unit sales and pricing power.
KMX presents a mixed outlook with valuation support (P/S 0.28) offset by margin pressure and high debt load. Analyst consensus targets $58.89 (9.5% upside) but technical weakness suggests near-term consolidation. Key risks include used car market volatility and interest rate sensitivity given $18.1B long-term debt. The turnaround story requires sustained execution to justify current multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
